News

Hongene Supports Clinical Advancement of siRNA DNV001 Using Proprietary Chemoenzymatic Ligation Platform SINGAPORE (July 10th, 2025) – Hongene Biotech Corporation, a contract development and ...
rs6190 helps men build muscle mass and reduce diabetes risk, but increases cholesterol levels and elevates the risk of ...